GenMark Diagnostics (GNMK) PT Raised to $18 at BTIG as COVID-19 Testing Drives Another Outsized Quarter
Tweet Send to a Friend
BTIG analyst Sung Ji Nam raised the price target on GenMark Diagnostics (NASDAQ: GNMK) to $18.00 (from $14.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
